Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin β subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 8, 2005, Pages 886-889

  Massart, Catherine ^a   Lucas, Catherine ^a   Rioux Leclercq, Nathalie ^a   Fergelot, Patricia ^a   Pouvreau Quillien, Véronique ^b   Volatron, Anne Claire ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b CRLCC   (France)

Author keywords

human chorionic gonadotropin (hCG ); Cholangiocarcinoma; Cross reaction; Human chorionic gonadotropin (hCG); Pregnancy diagnosis

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; AUTOMATION; BILE DUCT CARCINOMA; CARCINOMA CELL; CASE REPORT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE ANALYSIS; FOLLOW UP; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIVER TRANSPLANTATION; PERITONEUM METASTASIS; PREGNANCY TEST; PRIORITY JOURNAL; RADIOMETRY;

ADULT; BLOOD CHEMICAL ANALYSIS; CHOLANGIOCARCINOMA; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DIMERIZATION; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SENSITIVITY AND SPECIFICITY;

EID: 26844453616     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.150     Document Type: Article

References (18)

1. Braunstein GD, Rasor J, Adler D, Danzer H, Wade ME. Serum human chorionic gonadotropin levels throughout normal pregnancy. Am J Obstet Gynecol 1976;15:678-81.
2. Cole LA, Kroll TG, Ruddon RW, Hussa RO. Differential occurrence of free β and free α subunits of human chorionic gonadotropin (hCG) in pregnancy sera. J Clin Endocrinol Metab 1984;58:1200-2.
3. Alfthan H, Schröder J, Fraser R, Kosimies A, Hadila H, Stenman UH. Choriogonadotropin and its β subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorimetric assays. Clin Chem 1988;34:1758-62.
4. Thomas CM, Reijnders FJ, Segers MF, Doesburg WH, Rolland R. Human choriogonadotropin (hCG): comparisons between determinations of intact hCG, free hCG β-subunit, and "total" hCG+β in serum during the first half of high-risk pregnancy. Clin Chem 1990; 36:651-5.
5. Vaitukaitis JL, Ebersole ER. Evidence for altered synthesis of human chorionic gonadotropin in gestational trophoblastic tumors. J Clin Endocrinol Metab 1975;42:1048-55.
6. Mann K, Karl HJ. Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer. Cancer 1983;52:654-60.
7. Iles RK, Purkis PE, Whitehead PC, Oliver RT, Leigh I, Chard T. Expression of beta human chorionic gonadotropin by nontrophoblastic non-endocrine "normal" and malignant epithelial cells. Br J Cancer 1990;61:663-6.
8. Nishimura R, Koizumi T, Morisue K, Yamanaka N, Lalwani R, Yoshimura M, et al. Expression and secretion of the β subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro. Cancer Res 1995;55:1479-84.
9. Alfthan H, Haglund C, Roberts P, Stenman UH. Elevation of free β subunit of human choriogonadotropin and core β fragment of human choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992;52:4628-33.
10. Cole LA, Sutton JM, Higgins TN, Cembrowski GS. Between-method variation in human chorionic gonadotropin test results. Clin Chem 2004;50:874-82.
11. Stenman UH. Standardization of assays for human chorionic gonadotropin. Clin Chem 2004;50:798-800.
12. Rotmensch S, Cole LA. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 2000;355:712-5.
13. Morrish DW, Marusyk H, Sly O. Demonstration of specific secretory granules for human chorionic gonadotropin in placenta. J Histochem Cytochem 1987;35:93:101.
14. Louhimo J, Nordling S, Alfthan H, Von Boguslawski K, Stenman UH, Haglund C. Specific staining of human chorionic gonadotropin β in benign and malignant gastrointestinal tissues with monoclonal antibodies. Histopathology 2001;38:418-24.
15. Korhonen J, Alfthan H, Ylöstalo P, Veldhuis J, Stenman UH. Disappearance of human chorionic gonadotropin and its α and β-subunits after term pregnancy. Clin Chem 1997;43:2155-63.
16. Cole LA, Shahabi S, Bultler SA, Mitchell H, Newlands ES, Behrman HR, et al. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem 2001;47:308-15.
17. Birken S, Krichevsky A, O'Connor J, Schlatterer J, Cole L, Kardana A, et al. Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy and choriocarcinoma hCG. Endocrine 1999;10:137-44.
18. Stenman UH, Alfthan H, Hotakainen K. Human chorionic gonadotropin in cancer. Clin Biochem 2004;37:549-61.